TipRanks
Edesa Biotech Inc (DE:RBTQ)
FRANKFURT:RBTQ
Germany Market
RBTQ
Edesa Biotech
RESEARCH TOOLSreports

Edesa Biotech (RBTQ) Income Statement

0 Followers

Edesa Biotech Income Statement

Last quarter (Q3 2026), Edesa Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Edesa Biotech's net income was $-5.41M. See Edesa Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -119.27K$ 0.00$ 0.00$ 0.00$ -118.79K
Operating Expenses
$ 7.79M$ 7.01M$ 9.22M$ 18.37M$ 23.68M
Depreciation and Amortization
$ 119.27K$ 186.05K$ 183.47K$ 118.19K$ 118.79K
EBITDA
$ -7.07M$ -6.13M$ -8.46M$ -17.47M$ -13.22M
Operating Income
$ -7.91M$ -7.01M$ -9.22M$ -18.37M$ -23.68M
Other Income/Expenses
$ 726.84K$ 845.50K$ 849.14K$ 822.67K$ 10.34M
Pretax Income
$ -7.18M$ -6.17M$ -8.37M$ -17.55M$ -13.34M
Net Income
$ -7.19M$ -6.17M$ -8.37M$ -17.55M$ -13.34M
Per Share Metrics
Basic EPS
$ -1.27$ -1.93$ -2.93$ -8.37$ -7.74
Diluted EPS
$ -1.27$ -1.93$ -2.93$ -8.37$ -7.73
Weighted Average Shares Outstanding
 5.68M 3.20M 2.86M 2.10M 1.73M
Weighted Average Shares Outstanding (Diluted)
 5.68M 3.20M 2.86M 2.10M 1.73M
Currency in USD

Edesa Biotech Earnings and Revenue History